Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 368.03% | 371.43% | -35.26% | -31.07% | -195.46% |
| Total Depreciation and Amortization | 0.07% | 1.34% | 10.68% | 17.83% | 90.53% |
| Total Amortization of Deferred Charges | -56.39% | -55.82% | -37.61% | -33.58% | 1,169.91% |
| Total Other Non-Cash Items | -427.02% | -431.20% | -577.55% | -608.45% | -30.36% |
| Change in Net Operating Assets | -98.55% | -98.53% | 145.38% | 148.31% | 148.32% |
| Cash from Operations | 846.96% | 856.47% | -18.53% | -13.26% | -219.91% |
| Capital Expenditure | -151.14% | -154.34% | -47.80% | -57.40% | 64.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.98% | 79.69% | 29.74% | 25.19% | -100.17% |
| Cash from Investing | -98.85% | -101.40% | 166.68% | 171.03% | -100.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 15.33% | 15.33% | -- |
| Issuance of Common Stock | -85.96% | -85.96% | 61.30% | 61.30% | -77.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 55.99% | 55.99% | 268.18% | 268.18% | 99.67% |
| Cash from Financing | 99.94% | 99.94% | 23.53% | 18.58% | -13.62% |
| Foreign Exchange rate Adjustments | 57.20% | 56.67% | 1,000.00% | 1,058.46% | 77.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.23% | 215.69% | 16.81% | 24.37% | -185.66% |
